Title: Alterations of Brain Activity Regions in Neurological Disorders at Rest

Biography:

Prof. Emeritus Radu Mutihac is Chair of Medical Physics Section, University of Bucharest, and works in Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence. As postdoc/research associate/visiting professor/full professor, he run his research at the University of Bucharest, International Centre for Theoretical Physics (Italy), Ecole Polytechnique and Institut Henri Poincaré (France), KU Leuven (Belgium). Data mining and exploratory analysis of neuroimaging time series were addressed during two Fulbright Grants in Neuroscience (Yale University, CT, and the University of New Mexico, NM, USA). His research in fused biomedical imaging modalities was carried out at the Johns Hopkins University, National Institutes of Health, and Walter Reed Army Institute of Research, MD, USA.

Title: The dysfunction of quantum-sensitive cGMP- dependent Ca efflux from the cells as a target for age-dependent nerve disorder therapy

Biography:

Sinerik Ayrapetyan has completed his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev. He is the Head of Research Council and the Coordinator of UNESCO Chair in Life Sciences at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. His current research interest is “Intracellular Signaling System in Norm and Pathology”. He has published 7 international books and 115 papers. He is an Editor in Chief of the journal “Bioavailability and Bioequivalence”, and a Member of Editorial Board of the journals: “Electromagnetic Biology and Medicine”, “Journal of International Dental and Medical Research”, “ISRN Biophysics”, “Advances in Life Sciences”, “Applied Pharmacy”, “European Journal of Biophysics”, “Biochimica et Biophysica Acta” etc. He is a member of International Coordination Council of WHO and a number of professional international societies.

Title: Therapeutic ketosis and the broad field of applications for the ketogenic diet: Ketone ester applications & clinical updates

Biography:

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hired as a Postdoctoral Scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, on two research grants funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. He has written and lectured widely worldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Title: The Potential Use of 1,2-Diacetylbenzene as a Model for Cognitive Impairment in Alzheimer's and Parkinson's Disease Research

Title: Gene expression changes in PD patients leukocytes prior to and following DBS

Title: Suicide risk management of Psychiatric patients

Biography:

Fatma AYHAN is a assistant professor in the field of Mental Health and Psychiatric Nursing. She holds a master's 39;s degree in anatomy and nursing; bachelor's of Nursing and Sociology. She received her PhD in the Department of Psychiatric Nursing. She works on risk assessment, risk management, mental health, attachment.

Title: Neural biomarkers for Parkinson`s disease: a study through noninvasive EEG and minimally invasive DBS electrodes implanted pulse generators

Biography:

Professor Raju, presently involved in developing and applying new estimation, systems and control-tools in order to build computational simulation- statistical models of electrical-activity in neural-circuits affected by Parkinson`s disease, understand electro-physiological-dynamics of neural-circuits in both health and in disease-states during the DBS treatment, design more effective, adaptive, and safer DBS-strategies for neurological-neurodegenerative-disorders; design new clinical/clinico—statistical experiments, develop algorithms and apply systems-level mathematical-frameworks for modeling and controlling neuronal network activity in the brain with DBS, create a more intelligent system for both placing-and-controlling the electrodes; develop a semiconductor-based Silicon-chip (which functions as neural stimulator) and implant this intelligent microchip into the Parkinson`s disease patients (as a brain machine interface) that continuously measures and monitors neural-activity.